Error loading player: No playable sources found

Player size: small large

CT-SY49-1.5

SURMOUNT-OSA Trial Results and Potential Role of Tirzepatide in Treating Obesity-Related Obstructive Sleep Apnea (Includes Livestream)

Date

June 21, 2024

Speakers

Ania M. Jastreboff

Yale University School of Medicine

Atul Malhotra, MD

University of California, San Diego

Tracks

Clinical Diabetes/Therapeutics

Related Products

Thumbnail for Retatrutide Obesity—Efficacy and Safety Results of the 48-Week Obesity Phase 2 Trial

Retatrutide Obesity—Efficacy and Safety Results of the 48-Week Obesity Phase 2 Trial

Thumbnail for Diabetes and PAD—Epidemiology and Clinical Consequences

Diabetes and PAD—Epidemiology and Clinical Consequences

Thumbnail for Clinical Implications of Nutrient-Stimulated Hormone Pharmacotherapy

Clinical Implications of Nutrient-Stimulated Hormone Pharmacotherapy

Thumbnail for SURMOUNT-OSA—Efficacy and Safety

SURMOUNT-OSA—Efficacy and Safety